Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer.
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Irinotecan (Primary) ; Capecitabine
- Indications Rectal cancer
- Focus Adverse reactions; Pharmacogenomic
- 22 Nov 2011 New trial record